ENO1 and cancer: ENO1 overexpression is often associated with anti-ENO1 autoantibody responses and may have prognostic and diagnostic value in certain cancers (Table 1; Adamus et al., 1998; Tomaino et al., 2011; Pranay et al., 2013; Hsiao et al., 2015; Griggio et al., 2017; Zhang et al., 2020).